Dentsply International Given “Neutral” Rating at Zacks (XRAY)
Dentsply International (NASDAQ:XRAY)‘s stock had its “neutral” rating reiterated by Zacks in a report released on Wednesday, American Banking News reports. They currently have a $48.00 target price on the stock. Zacks‘ target price would suggest a potential upside of 5.06% from the company’s current price.
Zacks‘ analyst wrote, “DENTSPLY’s fourth-quarter 2013 earnings per share grew 8.9% to $0.61, beating the Zacks Consensus Estimate by a penny. Net revenues inched up 0.5% to $753.7 million but lagged the mark. Although revenues are improving steadily in the U.S., disappointing sales in Europe dampened its growth. However, a diversified product range and significant investments in product innovation should help the company expand its share in the dental market. Management expects a 4-9% rise in earnings per share in 2014 based on better global market conditions. As such, we reaffirm our Neutral recommendation on DENTSPLY with a target of $48.00.”
Several other analysts have also recently commented on the stock. Analysts at Ned Davis Research downgraded shares of Dentsply International from a “buy” rating to a “neutral” rating in a research note on Monday, February 10th. Separately, analysts at Credit Suisse upgraded shares of Dentsply International from a “neutral” rating to an “outperform” rating in a research note on Wednesday, December 11th. Finally, analysts at Goldman Sachs upgraded shares of Dentsply International from a “neutral” rating to a “buy” rating in a research note on Wednesday, December 11th. They now have a $56.00 price target on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $47.67.
Shares of Dentsply International (NASDAQ:XRAY) traded down 1.82% during mid-day trading on Wednesday, hitting $44.86. The stock had a trading volume of 667,256 shares. Dentsply International has a 52-week low of $39.90 and a 52-week high of $50.99. The stock has a 50-day moving average of $46.98 and a 200-day moving average of $45.71. The company has a market cap of $6.399 billion and a P/E ratio of 18.07.
Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $0.61 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.61. The company had revenue of $753.70 million for the quarter, compared to the consensus estimate of $767.89 million. Analysts expect that Dentsply International will post $2.57 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, April 11th. Shareholders of record on Friday, March 28th will be given a dividend of $0.0663 per share. This represents a $0.27 dividend on an annualized basis and a yield of 0.58%.
DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.